Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking an experienced in vivo research and laboratory operations professional with a strong background in rodent oncology models and vivarium operations. This senior-level position will independently lead the planning and execution of complex in vivo pharmacology studies in mice, provide day-to-day scientific and operational leadership for research associates, and serve as a key partner to scientists and cross-functional project teams. The role will help ensure consistent, high-quality study execution and support the continued growth and operational excellence of the vivarium. This position will also provide management oversight for weekend and holiday animal operations and serve as an escalation point for study, facility, and animal welfare issues.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior